Via Pharmaceuticals Inc. started an early safety test of a treatment for high LDL cholesterol.
The San Francisco drug company (Pink Sheets: VIAP) is testing the drug VIA-3196 in healthy volunteers at a center in Fargo, N.D. There will ultimately be about 72 people in this test. They’ll each get a single dose of the drug.
No comments:
Post a Comment